AGP Picks
View all

Science & Technology Watch
Provided by AGP

Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 3, 2026

Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
Jun. 3, 2026

Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026

Indeterminate GlobeNewswire
First Orion Expands INFORM® Branded Calling to Help Meet Customer Demand
Jun. 3, 2026

First Orion Expands INFORM® Branded Calling to Help Meet Customer Demand

Indeterminate GlobeNewswire
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
Jun. 3, 2026

Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome

Indeterminate GlobeNewswire
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
Jun. 3, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions

Indeterminate GlobeNewswire
Cherry Bekaert Selects Fieldguide as Strategic AI Partner to Modernize Audit and Advisory Delivery
Jun. 3, 2026

Cherry Bekaert Selects Fieldguide as Strategic AI Partner to Modernize Audit and Advisory Delivery

Indeterminate GlobeNewswire
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
Jun. 3, 2026

SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma

Indeterminate GlobeNewswire
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
Jun. 3, 2026

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

Indeterminate GlobeNewswire
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Jun. 3, 2026

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

Indeterminate GlobeNewswire
AlphaSense Raises $350M at $7.5B Valuation, and Surpasses $600M in Annual Recurring Revenue
Jun. 3, 2026

AlphaSense Raises $350M at $7.5B Valuation, and Surpasses $600M in Annual Recurring Revenue

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA
Jun. 3, 2026

Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA

Indeterminate GlobeNewswire
UAV Corp expecting an exciting 2026—Drone Airship Moving to Company Owned Airport
Jun. 3, 2026

UAV Corp expecting an exciting 2026—Drone Airship Moving to Company Owned Airport

Indeterminate GlobeNewswire
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
Jun. 3, 2026

Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity

Indeterminate GlobeNewswire
AlphaSense Introduces SuperAnalyst: The Always-On AI Agent for Decision-Grade Intelligence
Jun. 3, 2026

AlphaSense Introduces SuperAnalyst: The Always-On AI Agent for Decision-Grade Intelligence

Indeterminate GlobeNewswire
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
Jun. 3, 2026

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Indeterminate GlobeNewswire
Richtech Robotics Completes Strategic Acquisition of Warehouse Facility in Las Vegas to Accommodate Robotics and AI Powered Growth Objectives
Jun. 3, 2026

Richtech Robotics Completes Strategic Acquisition of Warehouse Facility in Las Vegas to Accommodate Robotics and AI Powered Growth Objectives

Indeterminate GlobeNewswire
Denovo to Participate in Upcoming Investor Conferences Highlighting its Biomarker Guided Phase 3 Antidepressant
Jun. 3, 2026

Denovo to Participate in Upcoming Investor Conferences Highlighting its Biomarker Guided Phase 3 Antidepressant

Indeterminate GlobeNewswire
Twin Disc to Present at Three Part Advisors Ideas Conference
Jun. 3, 2026

Twin Disc to Present at Three Part Advisors Ideas Conference

Indeterminate GlobeNewswire
Aduro Appoints Senior European Industrial Leader to Lead Delivery of FOAK Facility at Chemelot
Jun. 3, 2026

Aduro Appoints Senior European Industrial Leader to Lead Delivery of FOAK Facility at Chemelot

Indeterminate GlobeNewswire
NextGen Pathology Selects Proscia to Establish AI Foundation for Business Growth
Jun. 3, 2026

NextGen Pathology Selects Proscia to Establish AI Foundation for Business Growth

Indeterminate GlobeNewswire
Powerus and Swarmer Sign MOU to Explore Autonomous Swarming Integration
Jun. 3, 2026

Powerus and Swarmer Sign MOU to Explore Autonomous Swarming Integration

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science & Technology Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.